At this time, posts about Dongwha Pharm are rapidly increasing on portals and stock communities, while foreign investors are tentatively estimated to have net sold 71,000 shares today. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals (such as Gas Hwal Myung Su and Fusidin).

As of 11:31 AM on the 17th, Dongwha Pharm's stock price is 15,550 KRW, down 2.51% from the previous day, with a trading volume of 1,911,276 shares, which is about 77.4% of the 5-day average trading volume.

In addition to Dongwha Pharm, posts by investors are also rapidly increasing for Deokseongwoo (004835), Hanol Biopharma (009420), and RF Tech (061040).

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing